Sumbul, H.E.; Isik, B.; Mustan, A.G.; Alisan, I.; Erhan, C.; Koca, F.I.; Ucar, A.; Erdevir, M.; Avci, B.S.; Saracoglu Sumbul, M.;
et al. Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study. J. Clin. Med. 2026, 15, 4105.
https://doi.org/10.3390/jcm15114105
AMA Style
Sumbul HE, Isik B, Mustan AG, Alisan I, Erhan C, Koca FI, Ucar A, Erdevir M, Avci BS, Saracoglu Sumbul M,
et al. Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study. Journal of Clinical Medicine. 2026; 15(11):4105.
https://doi.org/10.3390/jcm15114105
Chicago/Turabian Style
Sumbul, Hilmi Erdem, Bektas Isik, Ahmet Gazi Mustan, Irfan Alisan, Cigdem Erhan, Fatma Inci Koca, Aysenur Ucar, Mehmet Erdevir, Begum Seyda Avci, Merve Saracoglu Sumbul,
and et al. 2026. "Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study" Journal of Clinical Medicine 15, no. 11: 4105.
https://doi.org/10.3390/jcm15114105
APA Style
Sumbul, H. E., Isik, B., Mustan, A. G., Alisan, I., Erhan, C., Koca, F. I., Ucar, A., Erdevir, M., Avci, B. S., Saracoglu Sumbul, M., Ozturk, D. D., Ardic, M. L., Ozturk, H. A., Arıcı, F. N., Dincer, C., Akbal, K., Pirinci, O., Koca, F., & Koc, M.
(2026). Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study. Journal of Clinical Medicine, 15(11), 4105.
https://doi.org/10.3390/jcm15114105
